These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 29027403

  • 1. Survival of gynecological cancers in Turkey: where are we at?
    Gultekin M, Dundar S, Kucukyildiz I, Karaca MZ, Boztas G, Turan SH, Hacikamiloglu E, Keskinkilic B.
    J Gynecol Oncol; 2017 Nov; 28(6):e85. PubMed ID: 29027403
    [Abstract] [Full Text] [Related]

  • 2. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina.
    Kosary CL.
    Semin Surg Oncol; 1994 Nov; 10(1):31-46. PubMed ID: 8115784
    [Abstract] [Full Text] [Related]

  • 3. Survival of Danish cancer patients 1943-1987. Female genital organs.
    Kjaer SK, Storm HH.
    APMIS Suppl; 1993 Nov; 33():107-21. PubMed ID: 8512734
    [Abstract] [Full Text] [Related]

  • 4. Trends in the survival of patients diagnosed with cancer in female genital organs in the Nordic countries 1964-2003 followed up to the end of 2006.
    Klint A, Tryggvadóttir L, Bray F, Gislum M, Hakulinen T, Storm HH, Engholm G.
    Acta Oncol; 2010 Jun; 49(5):632-43. PubMed ID: 20307243
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Reliability of recording uterine cancer in death certification in France and age-specific proportions of deaths from cervix and corpus uteri.
    Rogel A, Belot A, Suzan F, Bossard N, Boussac M, Arveux P, Buémi A, Colonna M, Danzon A, Ganry O, Guizard AV, Grosclaude P, Velten M, Jougla E, Iwaz J, Estève J, Chérié-Challine L, Remontet L.
    Cancer Epidemiol; 2011 Jun; 35(3):243-9. PubMed ID: 21106450
    [Abstract] [Full Text] [Related]

  • 7. Trends of Gynecological Cancers in Turkey: Toward Europe or Asia?
    Gultekin M, Kucukyildiz I, Karaca MZ, Dundar S, Boztas G, Turan SH, Hacikamiloglu E, Keskinkilic B.
    Int J Gynecol Cancer; 2017 Oct; 27(8S Suppl 1):S1-S9. PubMed ID: 28937544
    [Abstract] [Full Text] [Related]

  • 8. Trends of Gynecological Cancers in Turkey: Toward Europe or Asia?
    Gultekin M, Kucukyildiz I, Karaca MZ, Dundar S, Boztas G, Turan SH, Hacikamiloglu E, Keskinkilic B.
    Int J Gynecol Cancer; 2017 Sep; 27(7):1525-1533. PubMed ID: 28708790
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Gynecologic cancers: factors affecting survival after pulmonary metastasectomy.
    Clavero JM, Deschamps C, Cassivi SD, Allen MS, Nichols FC, Barrette BA, Larson DR, Pairolero PC.
    Ann Thorac Surg; 2006 Jun; 81(6):2004-7. PubMed ID: 16731120
    [Abstract] [Full Text] [Related]

  • 12. Gynecological cancers: cervix, corpus uteri, ovary.
    Zambon P, La Rosa F.
    Epidemiol Prev; 2004 Jun; 28(2 Suppl):68-74. PubMed ID: 15281609
    [Abstract] [Full Text] [Related]

  • 13. Clinicopathologic features, incidence, and survival trends of gynecologic neuroendocrine tumors: a SEER database analysis.
    Gibbs J, Mei S, Economos K, Lee YC, Kanis MJ.
    Am J Obstet Gynecol; 2019 Jul; 221(1):53.e1-53.e6. PubMed ID: 30849352
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
    Huang YT, Wang CC, Tsai CS, Lai CH, Chang TC, Chou HH, Lee SP, Hong JH.
    Int J Radiat Oncol Biol Phys; 2012 Oct 01; 84(2):420-7. PubMed ID: 22365621
    [Abstract] [Full Text] [Related]

  • 16. Trends in gynecologic cancer in Japan: incidence from 1980 to 2019 and mortality from 1981 to 2021.
    Nakai H, Higashi T, Kakuwa T, Matsumura N.
    Int J Clin Oncol; 2024 Apr 01; 29(4):363-371. PubMed ID: 38381162
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Survival differences in women with serous tubal, ovarian, peritoneal, and uterine carcinomas.
    Usach I, Blansit K, Chen LM, Ueda S, Brooks R, Kapp DS, Chan JK.
    Am J Obstet Gynecol; 2015 Feb 01; 212(2):188.e1-6. PubMed ID: 25149685
    [Abstract] [Full Text] [Related]

  • 19. Incidence and survival trends of uncommon corpus uteri malignancies in the Netherlands, 1989-2008.
    Boll D, Verhoeven RH, van der Aa MA, Pauwels P, Karim-Kos HE, Coebergh JW, van Doorn HC.
    Int J Gynecol Cancer; 2012 May 01; 22(4):599-606. PubMed ID: 22398706
    [Abstract] [Full Text] [Related]

  • 20. Stage at diagnosis and mortality in patients with adenocarcinoma and adenosquamous carcinoma of the uterine cervix diagnosed as a consequence of cytologic screening.
    Kinney W, Sawaya GF, Sung HY, Kearney KA, Miller M, Hiatt RA.
    Acta Cytol; 2003 May 01; 47(2):167-71. PubMed ID: 12685183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.